ArticleTransplantation2017

Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.

James Salazar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.